Comparing Naproxen to Sumatriptan for Emergency Headache Patients
Completed · Phase 4
Conditions studied: Migraine, Tension-type Headache, Primary Headache Disorder
In brief
2/3 of patients discharged from an emergency department after treatment for an acute headache will still be bothered by headache within 24 hours of emergency department (ED) treatment. The goal of this study is to compare two medications, naproxen and sumatriptan, to determine which is better for the treatment of recurrent headache within 24 hours of emergency department discharge.
Key facts
- Study ID
- NCT00449787
- Run by
- Montefiore Medical Center
- People needed
- 401
- Starts
- 2007-03-01
- Expected to finish
- 2009-07-01
- Last updated by the study team
- 2018-05-31
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Treated in the emergency department for acute primary headache
You may not qualify if…
- Allergy, intolerance, or contra-indication to one of the study medications
Where it is running
- Columbia University Medical Center — New York, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.